Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20640391 | 0.88 | ALDH1A1 (0.38) | ALDH1A1TDP1CYP3A4TSHRL3MBTL1 | |
| SCHEMBL9214132 | 0.84 | LMNA (0.45) | ALDH1A1TDP1CYP3A4TSHRL3MBTL1 | |
| SCHEMBL10670984 | 0.83 | — | — | |
| SCHEMBL5810093 | 0.80 | LMNA (0.45) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL10813417 | 0.78 | ALDH1A1 (0.48) | ALDH1A1TDP1CYP3A4TSHRL3MBTL1 | |
| SCHEMBL3884739 | 0.77 | LMNA (0.31) | — | |
| SCHEMBL1447691 | 0.76 | ALDH1A1 (0.39) | ALDH1A1TDP1CYP3A4TSHRL3MBTL1 | |
| SCHEMBL2532944 | 0.76 | — | — | |
| SCHEMBL14812440 | 0.75 | — | — | |
| SCHEMBL9213515 | 0.75 | LMNA (0.45) | ALDH1A1TDP1CYP3A4TSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10202322-B2 | Resorcinol derivatives | SUTTER BAY HOSPITALS (US) | 2019-02-12 | — | — | US | claimed |
| US-20180170846-A1 | RESORCINOL DERIVATIVES | SUTTER WEST BAY HOSPITALS | 2018-06-21 | — | — | US | claimed |
| US-20130209483-A1 | CANNABIDINOID DERIVATIVES | SUTTER WEST BAY HOSPITALS (US) | 2013-08-15 | — | — | US | claimed |
| EP-3898625-B1 | NOVEL COMPOUNDS AND THEIR USE IN THERAPY | IMPERIAL COLLEGE INNOVATIONS LTD (GB) | 2024-04-17 | — | — | EP | disclosed |
| US-20220064158-A1 | NOVEL COMPOUNDS AND THEIR USE IN THERAPY | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2022-03-03 | — | — | US | disclosed |
| EP-3898625-A1 | NOVEL COMPOUNDS AND THEIR USE IN THERAPY | Imperial College Innovations Limited (GB) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020128473-A1 | NOVEL COMPOUNDS AND THEIR USE IN THERAPY | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2020-06-25 | — | — | WO | disclosed |
| US-10202322-B2 | Resorcinol derivatives | SUTTER BAY HOSPITALS (US) | 2019-02-12 | — | — | US | disclosed |
| US-20180170846-A1 | RESORCINOL DERIVATIVES | SUTTER WEST BAY HOSPITALS | 2018-06-21 | — | — | US | disclosed |
| US-9809521-B2 | Cannabidinoid derivatives | SUTTER WEST BAY HOSPITALS (US) | 2017-11-07 | — | — | US | disclosed |
| US-20160376211-A1 | CANNABIDINOID DERIVATIVES | SUTTER WEST BAY HOSPITALS | 2016-12-29 | — | — | US | disclosed |
| EP-1296991-B1 | SILOXY SUBSTITUTED COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2013-05-15 | — | — | EP | disclosed |
| CN-1178960-C | Siloxy substituted cocatalyst activators for olefin polymerization | 埃克森美孚化学专利公司 | 2004-12-08 | — | — | CN | disclosed |
| CN-1172964-C | Nitrogen-containing group 13 anionic compound for olefin polymerization | ����ɭ���ڻ�ѧר����˾ | 2004-10-27 | — | — | CN | disclosed |
| CN-1437607-A | Siloxy substituted cocatalyst activators for olefin polymerization | EXXONMOBIL CHEM PATENTS INC (US) | 2003-08-20 | — | — | CN | disclosed |
| CN-1427849-A | Nitrogen-Containing group-13 anionic compounds for olefin polymerization | EXXONMOBIL CHEM PATENTS INC (US) | 2003-07-02 | — | — | CN | disclosed |
| EP-1296991-A1 | SILOXY SUBSTITUTED COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2003-04-02 | — | — | EP | disclosed |
| EP-1297027-A1 | SILOXY SUBSTITUTED COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2003-04-02 | — | — | EP | disclosed |
| WO-2002000738-A1 | SILOXY SUBSTITUTED COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2002-01-03 | — | — | WO | disclosed |
| WO-2002000666-A1 | SILOXY SUBSTITUTED COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2002-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10202322-B2 | Resorcinol derivatives | CNR1, CNR2, RCOR1 | ALDH1A1 1955/4885TDP1 3021/4885CYP3A4 336/4885 |
| US-20220064158-A1 | NOVEL COMPOUNDS AND THEIR USE IN THERAPY | PLAAT2, PLAAT3, ACAT2 | ALDH1A1 4324/4885TDP1 1410/4885CYP3A4 4699/4885 |
| US-20130209483-A1 | CANNABIDINOID DERIVATIVES | CNR2, CNR1, GPR18 | ALDH1A1 3491/4885TDP1 2676/4885CYP3A4 1389/4885 |
| US-20160376211-A1 | CANNABIDINOID DERIVATIVES | CNR2, CNR1, GPR18 | ALDH1A1 3491/4885TDP1 2676/4885CYP3A4 1389/4885 |
| US-20180170846-A1 | RESORCINOL DERIVATIVES | CNR1, CNR2, RCOR1 | ALDH1A1 1955/4885TDP1 3021/4885CYP3A4 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.